由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
Immigration版 - Paper Review Opportunity (Chemistry - Controlled Drug Release)
相关主题
审稿机会——Nanotechnology:JMM[gone] review opportunity: Journal of Pharmaceutical and Biomedic
需要审稿的看过来,biomedicine and pharmacotherapy IF 2.0, 药物制剂方向纳米粒求REVIEW,包子谢 :Drug delivery, anticancer, polymer
求帮忙下载一片文章。Journal:Expert Opinion on Pharmacothe生物医学审稿机会
EB1A, intent to deny, approved in TSCIs it possible for EB1A with low citations?
请教这样的情况还是忍不住上来问EB1-A的claim,恳请路过并给以指点
looking for review opportunities in the field of Natural Product Chemistry转过研究方向怎么办?
【DONE】转个manuscript review, biotecheb1a I40 approved
求下载一篇文章Good news from God! EB1b with PP approved on 03/04
相关话题的讨论汇总
话题: paper话题: controlled话题: release话题: review话题: drug
进入Immigration版参与讨论
1 (共1页)
r******u
发帖数: 31
1
rt
c**********l
发帖数: 27
2
楼主,我有兴趣,
Name: Jinsong TAO, Ph.D/Associate Professor
Email:[email protected]/* */
Research:Nanomaterials and nanotechnique application in anticancer
Affiliation/Institution:University of Maryland/South China University of
Technology
Professor Tao works for South China University of Technology (SCUT) in the
Top 1 major-ranked state key laboratory in China, Meanwhile, he is also a
visitor scholar of Materials Sci. and Eng. Dept. of University of Maryland
in USA.
His interests is as the follwing: Nanomaterials and nanotechnique
application in anticancer, such as targeted drug(Gold nanoparticles,AuNPs
photothermal and radiosensitization therapy, nanopaticles encapsulated
Curcumin,CUR and Cisplatin DDP), nanoparticles delivery system( lipid-
polymer hybrid nanoparticles, LPNs; polymeric nanoparicles, PNPs)
His publications related with materials are as the following,
(1) Yonggang Yao$, Jinsong Tao$,1Jianhua Zou$, Bilun Zhang, Junbiao Peng,
Liangbing Hu*,etc. Light management in plastic-paper hybrid substrate
towards high-performance optoelectronics, Energy Environ. Sci., 2016 DOI:10
.1039/C6EE01011C (IF=25.4)
The Journals he has served as a reviewer are as the following:
(1) 《Advanced Functional Materials》 IF 11.05
(2) 《Nanaoscale》 IF 7.76
(3) 《Chemical Engineering Journal》 IF 5.321
(4) 《Analytica Chimica Acta》 IF 4.712
(5) 《Biomedicine & Pharmacotherapy》 IF 2.326
(6) 《International Journal of Photoenergy》 IF 1.226
1 (共1页)
进入Immigration版参与讨论
相关主题
Good news from God! EB1b with PP approved on 03/04请教这样的情况
TSC EB1B PP simple RFElooking for review opportunities in the field of Natural Product Chemistry
绿了 DIY TSC RD 03/09/2011 with Background【DONE】转个manuscript review, biotech
TSC EB1A I140 RFE Approved 11/30求下载一篇文章
审稿机会——Nanotechnology:JMM[gone] review opportunity: Journal of Pharmaceutical and Biomedic
需要审稿的看过来,biomedicine and pharmacotherapy IF 2.0, 药物制剂方向纳米粒求REVIEW,包子谢 :Drug delivery, anticancer, polymer
求帮忙下载一片文章。Journal:Expert Opinion on Pharmacothe生物医学审稿机会
EB1A, intent to deny, approved in TSCIs it possible for EB1A with low citations?
相关话题的讨论汇总
话题: paper话题: controlled话题: release话题: review话题: drug